NYSE:EHC - Encompass Health Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $59.23 -0.29 (-0.49 %) (As of 05/24/2019 02:50 PM ET)Previous Close$59.52Today's Range$59.02 - $59.8752-Week Range$56.74 - $82.46Volume29,884 shsAverage Volume858,720 shsMarket Capitalization$5.86 billionP/E Ratio16.29Dividend Yield1.80%Beta0.74 ProfileAnalyst RatingsChartDividendEarningsHeadlinesOptions ChainSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families to address patients' physical needs, including pain control and symptom management, and to provide emotional and spiritual support. As of February 21, 2019, Encompass Health Corporation operated 130 hospitals, and 278 home health and hospice agencies in 36 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama. Receive EHC News and Ratings via Email Sign-up to receive the latest news and ratings for EHC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Hospitals Sub-IndustryN/A SectorMedical Current SymbolNYSE:EHC Previous Symbol CUSIPN/A CIKN/A Webhttp://www.encompasshealth.com/ Phone205-967-7116Debt Debt-to-Equity Ratio1.71 Current Ratio0.89 Quick Ratio0.89Price-To-Earnings Trailing P/E Ratio16.29 Forward P/E Ratio15.59 P/E Growth2.01 Sales & Book Value Annual Sales$4.28 billion Price / Sales1.37 Cash Flow$5.6517 per share Price / Cash Flow10.48 Book Value$16.35 per share Price / Book3.62Profitability EPS (Most Recent Fiscal Year)$3.63 Net Income$292.30 million Net Margins7.14% Return on Equity23.82% Return on Assets7.11%Miscellaneous Employees30,060 Outstanding Shares98,853,000Market Cap$5.86 billion Next Earnings DateN/A OptionableOptionable Encompass Health (NYSE:EHC) Frequently Asked Questions What is Encompass Health's stock symbol? Encompass Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EHC." How often does Encompass Health pay dividends? What is the dividend yield for Encompass Health? Encompass Health declared a quarterly dividend on Friday, May 3rd. Investors of record on Monday, July 1st will be paid a dividend of $0.27 per share on Monday, July 15th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 1.82%. The ex-dividend date is Friday, June 28th. View Encompass Health's Dividend History. How were Encompass Health's earnings last quarter? Encompass Health Corp (NYSE:EHC) posted its quarterly earnings results on Thursday, April, 25th. The company reported $1.04 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.89 by $0.15. The business had revenue of $1.12 billion for the quarter, compared to analyst estimates of $1.11 billion. Encompass Health had a return on equity of 23.82% and a net margin of 7.14%. View Encompass Health's Earnings History. What price target have analysts set for EHC? 6 equities research analysts have issued 1 year price targets for Encompass Health's shares. Their predictions range from $75.00 to $86.00. On average, they anticipate Encompass Health's share price to reach $80.75 in the next year. This suggests a possible upside of 36.3% from the stock's current price. View Analyst Price Targets for Encompass Health. What is the consensus analysts' recommendation for Encompass Health? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last year. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Encompass Health. Has Encompass Health been receiving favorable news coverage? News articles about EHC stock have trended negative this week, InfoTrie reports. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Encompass Health earned a news impact score of -2.9 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the near future. Who are some of Encompass Health's key competitors? Some companies that are related to Encompass Health include Ramsay Health Care Limited Fully Paid Ord. Shrs (RHC), Healthscope (HSO), MEDNAX (MD), Select Medical (SEM), Magellan Health (MGLN), Primary Health Care (PRY), Medical Facilities (DR), Capitol Health (CAJ), Animalcare Group (ANCR), SunLink Health Systems (SSY), Spine Injury Solutions (SPIN) and THC Biomed Intl (THC). What other stocks do shareholders of Encompass Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Encompass Health investors own include Edwards Lifesciences (EW), Proofpoint (PFPT), Brookfield Infrastructure Partners (BIP), Sociedad Quimica y Minera de Chile (SQM), Commercial Vehicle Group (CVGI), ImmunoGen (IMGN), Roadrunner Transportation Systems (RRTS), Gaming and Leisure Properties (GLPI), Independent Bank Group (IBTX) and Nasdaq (NDAQ). Who are Encompass Health's key executives? Encompass Health's management team includes the folowing people: Mr. Mark J. Tarr, CEO, Pres & Director (Age 57)Mr. Douglas E. Coltharp, Exec. VP & CFO (Age 57)Mr. John Patrick Darby, Exec. VP, Gen. Counsel & Corp. Sec. (Age 54)Ms. Barbara Ann Jacobsmeyer, Exec. VP & Pres Inpatient Hospitals (Age 53)Mr. Andrew L. Price, Sr. VP & Chief Accounting Officer (Age 52) How do I buy shares of Encompass Health? Shares of EHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Encompass Health's stock price today? One share of EHC stock can currently be purchased for approximately $59.23. How big of a company is Encompass Health? Encompass Health has a market capitalization of $5.86 billion and generates $4.28 billion in revenue each year. The company earns $292.30 million in net income (profit) each year or $3.63 on an earnings per share basis. Encompass Health employs 30,060 workers across the globe. What is Encompass Health's official website? The official website for Encompass Health is http://www.encompasshealth.com/. How can I contact Encompass Health? Encompass Health's mailing address is 9001 LIBERTY PARKWAY, BIRMINGHAM AL, 35242. The company can be reached via phone at 205-967-7116 or via email at [email protected] MarketBeat Community Rating for Encompass Health (NYSE EHC)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 104 (Vote Outperform)Underperform Votes: 90 (Vote Underperform)Total Votes: 194MarketBeat's community ratings are surveys of what our community members think about Encompass Health and other stocks. Vote "Outperform" if you believe EHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EHC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/24/2019 by MarketBeat.com StaffFeatured Article: Understanding Options Trading Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.